This study aimed to determine whether circulatory LCN2 could be a systemic biomarker in patients with IPF and to investigate the role of LCN2 in a bleomycin-induced lung injury mouse model. The gene discussed is LCN2; the disease is idiopathic pulmonary fibrosis.